early symptoms of ovarian cancer

Written by Liu Liang
Oncology
Updated on September 21, 2024
00:00
00:00

The early symptoms of ovarian cancer in patients are often not very obvious, so they are not easily noticed. The more common symptom is an abdominal mass, meaning you can feel a lump in the abdomen. In its early stages, the abdominal mass is not large and is not easily detectable. Most patients only discover it during gynecological examinations. As the disease progresses, the mass grows larger and the abdomen visibly expands, leading to symptoms like abdominal pain, bloating, or lower abdominal discomfort. Another symptom is ascites, which is a more common sign in patients with advanced ovarian cancer.

Other Voices

doctor image
home-news-image
Written by Wu Xia
Oncology
49sec home-news-image

Ovarian cancer requires the following examinations:

The examination for ovarian cancer begins with an abdominal ultrasound, which can clarify the tumor's size, shape, cystic or solid nature, location, and its relationship with neighboring organs. If necessary, CT scans and MRI can be conducted for a clearer view. Next are tumor markers, which are essential in the diagnosis of ovarian cancer. Additionally, CT scans of the lungs and head, or MRI, and a complete blood count of bone can help rule out distant metastasis. The most critical part is the pathological diagnosis, as the definitive diagnosis of tumors primarily relies on pathology. We can obtain a clear pathological diagnosis through laparoscopy or exploratory laparotomy.

doctor image
home-news-image
Written by Liu Liang
Oncology
39sec home-news-image

How many years can one live with ovarian cancer?

The survival period of ovarian cancer patients is influenced by various factors including the specific stage of the cancer, whether there is residual tumor after surgery, the size of any residual tumor, the pathological type of the cancer, the presence of high-risk factors for recurrence such as vascular tumor thrombus, neural invasion, lymph node metastasis, etc., as well as the patient's age, overall condition, the presence of severe comorbidities, and the patient's response and sensitivity to treatments like radiotherapy and chemotherapy. Survival periods vary due to differences in stages and treatment sensitivities, meaning it cannot be generalized; there is significant individual variation in survival outcomes.

doctor image
home-news-image
Written by Liu Liang
Oncology
46sec home-news-image

Location of abdominal pain in ovarian cancer

Ovarian cancer in patients manifests as tumors in either both ovaries or one ovary. Therefore, the abdominal pain they experience is lower abdominal pain, not bloating or sudden, noticeable increase in abdominal size. Additionally, the primary pathway for the metastasis of ovarian cancer is through implantation, allowing widespread metastatic implants in the pelvic and abdominal cavities. There is also local spread of the tumor to the uterus, fallopian tubes, and surrounding pelvic tissues. Thus, the location of abdominal pain in ovarian cancer is in the lower abdomen, specifically pain and bloating in the pelvic area.

doctor image
home-news-image
Written by Liu Liang
Oncology
41sec home-news-image

What is the level of cancer antigen for ovarian cancer?

Carcinoembryonic antigen is primarily found in malignant tumors of the digestive tract, such as colorectal cancer and gastric cancer, where it tends to be significantly elevated. It is also elevated in patients with lung adenocarcinoma. In cases of ovarian cancer, carcinoembryonic antigen may be elevated, but the most primary, sensitive, and specific tumor marker is CA125, which usually shows a significant increase. However, CA125 is specifically elevated in the pathological type of epithelial ovarian cancer.

doctor image
home-news-image
Written by Liu Liang
Oncology
1min 11sec home-news-image

Is ovarian cancer curable?

Early-stage ovarian cancer patients, meaning those without extensive ascites buildup, and without widespread implant metastasis in the pelvic and abdominal cavity, and without metastasis to distant organs like the liver and lungs. These very early-stage ovarian cancer patients can undergo radical surgery. Postoperative treatment decisions, such as whether postoperative adjuvant radiotherapy or chemotherapy is needed, are based on the postoperative pathological report, which looks for high-risk factors for recurrence such as vascular cancer emboli or neural invasion. Through these treatment approaches, very early-stage ovarian cancer patients can achieve a cure, but this is not absolute. It's not guaranteed that every early-stage ovarian cancer patient can be cured, as there are individual differences. Clinically, if there is no recurrence or metastasis within five years, it is considered a cure.